Obstetrics, gynecology and reproductive medicine guidelines

Female genital neoplasms

PubMed Free Full Text

Cervical cancer: human papillomavirus

 

Africa

• PLoS ONE
  • Prevalence of Human Papillomavirus Genotypes among African Women with Normal Cervical Cytology and Neoplasia: A Systematic Review and Meta-Analysis [2015]

Australia

• Australian Family Physician
  • HPV testing in the National Cervical Screening Program – when is it recommended? [2013]

• Australian Journal of General Practice
  • Human papillomavirus testing as part of the renewed National Cervical Screening Program [2018]

Bahrain

• BMC Cancer
  • An epidemiological study assessing the prevalence of human papillomavirus types in women in the Kingdom of Bahrain [2014]

Brazil

• Revista Brasileira de Ginecologia e Obstetrícia
  • Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil [2018]

Canada

• Canadian Agency for Drugs and Technologies in Health
  • HPV Testing for Primary Cervical Cancer Screening [2018]

• Canadian Family Physician
  • Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women [2017]

• Public Health Agency of Canada
  • Human Papillomavirus (HPV)

Croatia

• PLoS ONE
  • Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia [2017]

El Salvador

• International Journal of Cancer
  • The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador [2015]

• Journal of Lower Genital Tract Disease
  • Introducing a High-Risk HPV DNA Test Into a Public Sector Screening Program in El Salvador [2016]

Finland

• BMC Women's Health
  • The costs of offering HPV-testing on self-taken samples to non-attendees of cervical screening in Finland [2015]

International

• Clinical Microbiology and Infection
  • Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening? [2015]

• Diagnostic Cytopathology
  • Statement on HPV DNA Test Utilization [2009]

• International Journal of Cancer
  • Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women of 30 years and older [2009]

Ireland

• Health Protection Surveillance Centre
  • HPV

Italy

• Epidemiologia e Prevenzione
  • hr-HPV testing in the management of women with ASC-US+ and in the follow-up of women with cytological abnormalities and negative colposcopy. Recommendations of the Italian group for cervical cancer screening (GISCi) [2015]
  • A first survey of HPV-based screening in routine cervical cancer screening in Italy [2015]

Latin America

• PLoS ONE
  • Type-Specific HPV Prevalence in Cervical Cancer and High-Grade Lesions in Latin America and the Caribbean: Systematic Review and Meta-Analysis [2011]

Low and middle-income countries

• BMC Cancer
  • Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study [2017]

Netherlands

• International Journal of Cancer
  • Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening [2016]
  • Primary human papillomavirus DNA screening for cervical cancer prevention: Can the screening interval be safely extended? [2014]

New Zealand

• PLoS ONE
  • Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand [2016]

PAHO

• Pan American Health Organization
  • Integrating HPV testing in cervical cancer screening program: a manual for program managers [2016]

Slovenia

• Acta Dermatovenerologica Alpina, Pannonica et Adriatica
  • A review of 20 years of HPV research in Slovenia [2011]

Taiwan

• Chang Gung Medical Journal
  • Human papillomavirus research on the prevention, diagnosis, and prognosis of cervical cancer in Taiwan [2012]

United Kingdom

• Health Technology Assessment
  • The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds [2014]

• Public Health England
  • Human papillomavirus (HPV): primary screening protocol

United States of America

• Acta Cytologica
  • 2013 Statement on Human Papillomavirus DNA Test Utilization [2014]

• Agency for Healthcare Research and Quality
  • Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: A Systematic Evidence Review for the U.S. Preventive Services Task Force [2018]

• American Journal of Managed Care
  • The Budget Impact of Cervical Cancer Screening Using HPV Primary Screening [2016]

• Cancer Cytopathology
  • Primary human papillomavirus screening for cervical cancer in the United States—US Food and Drug Administration approval, clinical trials, and where we are today [2014]

• Centers for Disease Control and Prevention
  • CDC Grand Rounds: Reducing the Burden of HPV-Associated Cancer and Disease [2014]
  • Human Papillomavirus–Associated Cancers — United States, 2004–2008 [2012]
  • HPV | Professional Resources
  • HPV

• Journal of Women's Health
  • The Clinical and Economic Benefits of Co-Testing Versus Primary HPV Testing for Cervical Cancer Screening: A Modeling Analysis [2016]
  • Overview of the CDC Cervical Cancer (Cx3) Study: An Educational Intervention of HPV Testing for Cervical Cancer Screening [2013]

• Preventive Medicine
  • Primary HPV testing recommendations of US providers, 2015 [2017]

• Society of Gynecologic Oncology
  • Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance [2015]
  • Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test  [2015]

WHO

• World Health Organization
  • Human papillomavirus laboratory manual [2010]
  • Human papillomavirus (HPV) and cervical cancer: Fact sheet
  • Human papillomavirus (HPV)

{Related topics}

• Guidelines
  • HIV/AIDS and human papillomavirus
  • Condylomata acuminata (genital warts)
  • Cervical cancer